Mary Jane Staab

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

Douglas G. McNeel, Edward J. Dunphy, James G. Davies et al. · Journal of Clinical Oncology · 2009 · 250 citations · Full text

Medicine, Immunology, Oncology +17

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

Christopher J. Sweeney, Glenn Liu, Constantin T. Yiannoutsos et al. · Clinical Cancer Research · 2005 · 173 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma

Joshua M. Lang, Mahazarin R. Kaikobad, Marianne Wallace et al. · Cancer Immunology Immunotherapy · 2011 · 132 citations · Full text

Medicine, Immunology, Oncology +11

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer

Douglas G. McNeel, Heath A. Smith, Jens C. Eickhoff et al. · Cancer Immunology Immunotherapy · 2011 · 103 citations · Full text

Medicine, Oncology, Urology +14

Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer

Douglas G. McNeel, Jens C. Eickhoff, Ellen Wargowski et al. · Oncotarget · 2018 · 90 citations · Full text

Medicine, Immunology, Oncology +17